[MNPR] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[MNPR] Monopar Therapeutics Inc.
Announcement Date
08-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 34.16%
YoY- -10.35%
Quarter Report
MNPR's Result
MNPR's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -2,763 -2,080 -1,446 -906 -821 -591 -336 42.04%
Tax -1 -2,092 -1,464 -932 -840 -595 1 -
NP -2,762 -2,080 -1,446 -906 -821 -591 -336 42.04%
Tax Rate - - - - - - - -
Total Cost 2,762 2,080 1,446 906 821 591 336 42.04%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -0.22 -0.17 -0.14 -0.09 -0.07 -0.06 -0.04 32.84%
EPS Diluted -0.22 -0.17 -0.14 -0.09 -0.07 -0.06 -0.04 32.84%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.